🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
At two sites (Boston University and the University of Texas at Austin, unde...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-10-01
Trial ID
NCT04035603
The objective of this within-subject study is to test the effects of Episod...
Status
Suspended
Location
Fralin Biomedical Research Institute at VTC
Start Date
2024-06-28
Trial ID
NCT05901610
The primary objective is to test the theory of Reinforcer Pathology via man...
Status
Completed
Location
Fralin Biomedical Research Institute at VTC
Start Date
2022-11-30
Trial ID
NCT05507814
Treatments Being Tested
To confirm the tolerability and safety of combined administration of ONO-79...
Status
Active Not Recruiting
Location
Fujita Health University Hospital
Start Date
2021-09-23
Trial ID
NCT06540261
Treatments Being Tested
The current study aims to evaluate the efficacy of Enhanced Cue Exposure Th...
Status
Recruiting
Location
The University of Hong Kong
Start Date
2023-12-21
Trial ID
NCT06012045
Treatments Being Tested
This phase II trial tests how well photoimmunotherapy (PIT) with ASP-1929 i...
Status
Not Yet Recruiting
Location
Roswell Park Cancer Institute
Start Date
2026-08-15
Trial ID
NCT06943664
Treatments Being Tested
Cesareans are a frequent procedure in obstetrics and 15.4% (95% CI, 9.9-20....
Status
Terminated
Location
CHU clermont-ferrand
Start Date
2023-07-04
Trial ID
NCT05696301
Treatments Being Tested
Tinnitus (i.e., ringing in the ears) is currently the most prevalent disabi...
Status
Completed
Location
VA Portland Health Care System, Portland, OR
Start Date
2015-09-01
Trial ID
NCT02293512
Treatments Being Tested
Target-Controlled Infusion (TCI) of Propofol has been proved to be a safe a...
Status
Completed
Location
The Second Hospital of Dalian Medical University
Start Date
2015-11
Trial ID
NCT02927587
Treatments Being Tested
Erdafitinib (ERDA) alone or in combination with cetrelimab (CET) as neoadju...
Status
Recruiting
Location
CLCC Jean Perrin
Start Date
2023-03-07
Trial ID
NCT06511648
Treatments Being Tested